MedTrace Logo

Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis

NCT03665519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-01-26

No results posted yet for this study

Summary

This study evaluates the effect of sublimated mare milk supplement on patients with biliary cholangitis

Conditions

  • Primary Biliary Cirrhosis

Interventions

DIETARY_SUPPLEMENT

Sublimated mare milk

The dietary supplement mare milk product, which is obtained from fresh mare milk (few hours) through sublimation process.

DRUG

Ursodeoxycholic Acid

Ursodeoxycholic acid treatment will be given for 3 months.

Sponsors & Collaborators

  • Eurasia Invest Ltd.

    collaborator INDUSTRY

  • Ministry of Education and Science, Republic of Kazakhstan

    collaborator OTHER_GOV

  • National Scientific Medical Center, Kazakhstan

    lead OTHER_GOV

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-03
Primary Completion
2020-09-01
Completion
2020-12-01

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03665519 on ClinicalTrials.gov